Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6466)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2014 (publication date) through Dec 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tziomalos K. Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World J Hepatol 2014; 6(10): 738-744 [PMID: 25349644 DOI: 10.4254/wjh.v6.i10.738] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v6/i10/738.htm |
| Number | Citing Articles |
| 1 |
Konstantinos Tziomalos, Vasilios G. Athyros, Paschalis Paschos, Asterios Karagiannis. Nonalcoholic fatty liver disease and statins. Metabolism 2015; 64(10): 1215 doi: 10.1016/j.metabol.2015.07.003
|
| 2 |
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. Journal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
|
| 3 |
Stephen A. Harrison, Mark M. Pence, Amy N. Stratton, Dawn M. Torres. Zakim and Boyer's Hepatology. 2018; : 406 doi: 10.1016/B978-0-323-37591-7.00027-6
|
| 4 |
Hua Cao, Zhi-Xiang Chen, Kai Wang, Meng-Meng Ning, Qing-An Zou, Ying Feng, Yang-Liang Ye, Ying Leng, Jian-Hua Shen. Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect. Scientific Reports 2016; 6(1) doi: 10.1038/srep28676
|
| 5 |
Rachana S. Bhimanwar, Amit Mittal, Snehal Chaudhari, Vikas Sharma. Recent advancements in the structural exploration of TGR5 agonists for diabetes treatment. RSC Medicinal Chemistry 2024; 15(9): 3026 doi: 10.1039/D4MD00473F
|
| 6 |
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/647832
|
| 7 |
Aybike Birerdinc, Zobair Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?. Journal of Hepatology 2015; 62(4): 761 doi: 10.1016/j.jhep.2015.01.005
|
| 8 |
Haiyan Zhou, Maeda Toshiyoshi,, Wenli Zhao, Ye Zhao, Yan Zhao. Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs. Medicine 2023; 102(26): e33981 doi: 10.1097/MD.0000000000033981
|
| 9 |
Yajun Duan, Ke Gong, Suowen Xu, Feng Zhang, Xianshe Meng, Jihong Han. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01125-5
|
| 10 |
Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba. Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. Therapeutic Advances in Gastroenterology 2016; 9(2): 152 doi: 10.1177/1756283X15621232
|
| 11 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
|
| 12 |
Ju Youn Kim, Feng He, Michael Karin. From Liver Fat to Cancer: Perils of the Western Diet. Cancers 2021; 13(5): 1095 doi: 10.3390/cancers13051095
|
| 13 |
Adnan Hussain Gora, Saima Rehman, Viswanath Kiron, Jorge Dias, Jorge M. O. Fernandes, Pål Asgeir Olsvik, Prabhugouda Siriyappagouder, Ioannis Vatsos, Ulrike Schmid-Staiger, Konstantin Frick, Miguel Cardoso. Management of Hypercholesterolemia Through Dietary ß-glucans–Insights From a Zebrafish Model. Frontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.797452
|
| 14 |
Graciela Arguello, Elisa Balboa, Marco Arrese, Silvana Zanlungo. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1765 doi: 10.1016/j.bbadis.2015.05.015
|